UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form 6-K
Report
of Foreign Private Issuer
Pursuant
to Rule 13a-16 or 15d-16
under
the Securities Exchange Act of 1934
For
the month of November, 2023
Commission
File Number: 001-41106
Incannex
Healthcare Limited
(Exact
name of Registrant as specified in its charter)
not
applicable
(Translation
of Registrant’s name into English)
Australia
(Jurisdiction
of incorporation or organization)
Joel
Latham
Chief
Executive Officer and Managing Director
Level
39, Rialto South Tower
525 Collins Street
Melbourne
3000
Australia
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:
Form 20-F ☒
Form 40-F ☐
INFORMATION
CONTAINED IN THIS REPORT ON FORM 6-K
On November 17, 2023, The Australian Securities Exchange filed an announcement
captioned: “Suspension from Official Quotation”, a copy of which announcement is attached to this Form 6-K as Exhibit
99.1.
Signatures
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
| |
Incannex
Healthcare Limited |
| |
|
|
| Date: November 17,
2023 |
By: |
/s/ Joel
Latham |
| |
Name: |
Joel Latham |
| |
Title: |
Chief Executive Officer
and Managing Director |
INDEX
TO EXHIBITS
3
